Sigachi Industries Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

51.62

-1.07 (-2.03%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

51.62

-1.07 (-2.03%)
16:02 Dec 20

Quality

28/100
Low Financial Strength

Valuation

42/100
Mid Valuation

Technical

41/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	192.76	250.29	302.05	398.96	435.69
Operating Expenses +	153.97	197.25	243.32	322.3	358.53
Raw Material	97.91	123.47	142.36	200.27	227.02
Increase Decrease in Cost	2.82	-4.87	-3.98	-5.14	-11.34
Other Manufacturing Expense	18.19	19.86	24.49	31.1	0
Employee Cost	17.38	21.08	38.25	57.15	63.17
Miscellaneous Expenses	17.67	37.71	44.94	118.86	79.68
Operating Profit	38.79	53.04	58.73	76.66	77.16
Other Income	3.25	2.63	6.67	11.69	25.27
Depreciation	2.31	2.9	6.63	10.8	12.68
Interest	1.25	1.17	4.29	7.77	9.97
Profit before tax and exceptio..	38.48	51.6	54.48	69.77	79.78
Exceptional Items	0	0	0	0	0
PBT	38.48	51.6	54.48	69.77	79.78
Provision for Taxation	8.22	11.56	10.94	12.5	14.73
Net Profit	30.26	40.04	43.54	57.27	65.06
NET Profit after MI	30.26	40.04	43.54	57.18	66.09
EPS	13.13	15.44	14.16	1.54	2.05
Operating Profit Margin (%)	20.12	21.19	19.44	19.22	17.71
Net Profit Margin (%)	15.7	16	14.41	14.33	15.17

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	44.70	45.40	45.40	46.10	48.50
FII	1.60	1.60	2.10	1.80	1.00
MF	0.00	0.00	0.00	0.00	0.00
Public	53.70	53.00	52.50	52.20	50.60
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	-0.10	-0.10